Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
673 participants
INTERVENTIONAL
2016-08-31
2019-08-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Does Knowing One's Estimated Colorectal Cancer Risk Influence Screening Behavior?
NCT03819920
Improving Rates of Colorectal Cancer Screening Among Never Screened Patients
NCT01742169
Outreach and Choice in Colorectal Cancer Screening
NCT04940442
Effectiveness of Direct-to-Patient Outreach on Colorectal Cancer Screening Within a Low Income and Diverse Population
NCT01385579
ColoRectal Cancer Screening for Southern California Community Health Centers
NCT04941300
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
SCREENING
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Inreach strategy
This consists of a community health worker-delivered in clinic education regrading CRC screening with a fecal immunochemical test (FIT) kit, and telephone reminders.
Inreach strategy
Inreach strategy: In clinic education and delivery of fecal immunochemical test (FIT) kit
Outreach strategy
This consists of mailed invitations to complete screening with an enclosed fecal immunochemical test (FIT) kit and telephone reminders.
Outreach strategy
Outreach strategy: Mailed fecal immunochemical test (FIT) kit and telephone reminders
Both Inreach and Outreach strategies
This is a combination of the above two strategies: Inreach and Outreach combined.
Both Inreach and Outreach strategies
Both Inreach and Outreach strategies: Both In clinic education and delivery of fecal immunochemical test (FIT) kit and Mailed fecal immunochemical test (FIT) kit and telephone reminders
Usual care
Usual care in the clinic using the fecal immunochemical test (FIT) kit.
Usual care
Usual care: FIT kit delivery as part of usual care
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Inreach strategy
Inreach strategy: In clinic education and delivery of fecal immunochemical test (FIT) kit
Outreach strategy
Outreach strategy: Mailed fecal immunochemical test (FIT) kit and telephone reminders
Both Inreach and Outreach strategies
Both Inreach and Outreach strategies: Both In clinic education and delivery of fecal immunochemical test (FIT) kit and Mailed fecal immunochemical test (FIT) kit and telephone reminders
Usual care
Usual care: FIT kit delivery as part of usual care
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* One or more SYHC visits in the last year,
* Not uptodate with CRC screening
Exclusion Criteria
50 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
San Diego State University
OTHER
University of California, San Diego
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Samir Gupta
Associate Professor of Clinical Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Samir Gupta, MD
Role: PRINCIPAL_INVESTIGATOR
University of California, San Diego
Sheila Castaneda, PhD
Role: PRINCIPAL_INVESTIGATOR
San Diego State University
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
U54132379
Identifier Type: OTHER
Identifier Source: secondary_id
20153270
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.